CAS 1639208-54-0: Valbenazine tosylate

Description:Valbenazine tosylate is a pharmaceutical compound primarily used in the treatment of tardive dyskinesia, a movement disorder often associated with long-term use of antipsychotic medications. It functions as a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, which helps to regulate the release of neurotransmitters, particularly dopamine, in the brain. This mechanism is crucial for alleviating the involuntary movements characteristic of the disorder. Valbenazine tosylate is typically administered orally and is known for its relatively favorable side effect profile compared to other treatments for movement disorders. The compound is characterized by its solubility in organic solvents and has a specific molecular structure that contributes to its pharmacological activity. As with many medications, it is essential to monitor for potential side effects, including sedation and other neurological effects. Overall, Valbenazine tosylate represents a significant advancement in the management of tardive dyskinesia, providing patients with a targeted therapeutic option.

Found 2 products.

Brand	Product data	Purity	Price range	Estimated delivery
	Valbenazine tosylate REF: 3D-PQC20854CAS: 1639208-54-0	Min. 95%	To inquire	Wed 21 May 25
	Valbenazine tosylate REF: TM-T22452CAS: 1639208-54-0	98%	1,748.00 €~4,940.00 €	Wed 09 Jul 25